Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer.

× No keyword cloud information.

186 in total

1. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1.

Authors: D C Guttridge; C Albanese; J Y Reuther; R G Pestell; A S Baldwin
Journal: Mol Cell Biol Date: 1999-08 Impact factor: 4.272

Review 2. Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer.

Authors: R J Michalides
Journal: J Clin Pathol Date: 1999-08 Impact factor: 3.411

3. Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions.

Authors: J H Dannenberg; A van Rossum; L Schuijff; H te Riele
Journal: Genes Dev Date: 2000-12-01 Impact factor: 11.361

Review 4. Cell cycle checkpoints and their inactivation in human cancer.

Authors: M Molinari
Journal: Cell Prolif Date: 2000-10 Impact factor: 6.831

5. Cyclin-dependent kinases 4 and 6 control tumor progression and direct glucose oxidation in the pentose cycle.

Authors: Miriam Zanuy; Antonio Ramos-Montoya; Oscar Villacañas; Nuria Canela; Anibal Miranda; Esther Aguilar; Neus Agell; Oriol Bachs; Jaime Rubio-Martinez; Maria Dolors Pujol; Wai-Nang P Lee; Silvia Marin; Marta Cascante
Journal: Metabolomics Date: 2011-07-08 Impact factor: 4.290

6. Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice.

Authors: A E Lenferink; J F Simpson; L K Shawver; R J Coffey; J T Forbes; C L Arteaga
Journal: Proc Natl Acad Sci U S A Date: 2000-08-15 Impact factor: 11.205

Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer.

1. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1.

Review 2. Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer.

3. Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions.

Review 4. Cell cycle checkpoints and their inactivation in human cancer.

5. Cyclin-dependent kinases 4 and 6 control tumor progression and direct glucose oxidation in the pentose cycle.

6. Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice.

7. Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4.

Review 8. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer.

9. Dissecting the contribution of p16(INK4A) and the Rb family to the Ras transformed phenotype.

10. Requirement of cyclin E-Cdk2 inhibition in p16(INK4a)-mediated growth suppression.